Posting of Annual Report and Notice of AGM

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, today announces that its Annual Report and Accounts for the year ended 31 December 2021 and the Notice of the 2022 Annual General Meeting (‘AGM’) are now available on the Company’s website

Copies of the Annual Report and Accounts and the Notice of AGM have been posted to shareholders who have elected to receive them in paper form.

The Annual General Meeting will be held on Thursday, 23 June 2022 at 3.30 p.m. BST at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London EC1A 4HD. Shareholders who plan to attend are required to register their attendance and prove their shareholding by email to